9.370CAD-3.60%Mkt Cap: 466.53M $P/E: —Today
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap466.53M $
Enterprise Value371.67M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-28.09M $
Revenue/Share—
Last Price9.370 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.60
PEG—
EV/EBITDA-8.97
EV/Revenue—
P/S—
P/B6.64
EPS (TTM)-1.42
EPS (Forward)-1.45
52W Range
6.94041% of range12.86
52W High12.86 CAD
52W Low6.940 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.02%
ROA-44.78%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.79M $
CapEx (TTM)428.91K $
FCF Margin—
FCF Yield-2.95%
Net Debt-96.00M $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.00
Current Ratio16.00
Quick Ratio15.71
Book Value/Sh1.403 CAD
Cash/Share2.028 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.00 CAD
Upside (mean)+70.8%
Target Range14.00 CAD – 18.00 CAD
CAD14.00+70.8% to meanCAD18.00
# Analysts2
Ownership
Shares Out.65.91M
Float55.69M
Insiders14.22%
Institutions45.02%
Short Interest
Short Ratio1.4d
Short % Float0.17%
Short % Out.0.14%
Shares Short88.44K
Short (prev mo.)67.03K
Technical
SMA 509.101 (+3.0%)
SMA 2009.826 (-4.6%)
Beta1.50
S&P 52W Chg18.16%
Avg Vol (30d)58.74K
Avg Vol (10d)54.27K
Technical Indicators
RSI (14)59.0
MACD0.0951
MACD Signal0.0238
MACD Hist.+0.0713
BB Upper9.787 CAD
BB Middle9.044 CAD
BB Lower8.302 CAD
BB Width16.41%
ATR (14)0.4698 CAD
Vol Ratio (20d)2.84x